ans03

Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

Avistone Biotechnology Co., Ltd.Phase 1

—

Rating in progress

ans03 in Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active